All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.

A meta-analysis indicates HD-IIV is superior to SD-IIV for reducing hospitalizations in adults aged 65 years and older.

An mRNA influenza vaccine was approximately 35% more effective than an inactivated quadrivalent flu vaccine against two different strains, based on new data from a phase 3 randomized trial. Although ...

Influenza vaccination significantly reduces the risk of influenza-associated mortality in pediatric patients with or without underlying conditions.

Several companies, including GSK, Sanofi and CSL Seqirus are beginning to ship influenza vaccine for the upcoming season 2024/25 flu season. GSK has started shipping doses of its trivalent influenza ...

CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S ...

Moderna's mRNA flu vaccine could be approved by August, but federal policy and a nonfunctional advisory committee threaten ...

New research led by Oregon Health & Science University reveals a promising approach to developing a universal influenza vaccine—a so-called "one and done" vaccine that confers lifetime immunity ...

The study also reviews the great potential of mRNA vaccines to treat influenza, RSV, cancer, and autoimmune diseases.

Recognizing Influenza A Symptoms If you frequently experience high fever, body aches, a sore throat, and a cough during ...

Experts are urging Australians to roll up their sleeves as soon as the 2026 influenza vaccine becomes available, following last year's low vaccine uptake and high caseload. It comes as a fast-moving ...